ATE118351T1 - Wirkung von hormonen. - Google Patents

Wirkung von hormonen.

Info

Publication number: ATE118351T1
Authority: AT; Austria
Prior art keywords: pct; inhibin; sec; host; activin
Prior art date: 1988-05-31

Application number

AT89906681T

Other languages

English (en)

Inventor

Kretser David Morritz De

David Mark Milne-Robertson

Mark Peter Hedger

Original Assignee

Biotech Australia Pty Ltd

Univ Monash

Prince Henrys Inst Med Res

St Vincents Inst Med Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-31

Filing date

1989-05-31

Publication date

1995-03-15

1989-05-31 Application filed by Biotech Australia Pty Ltd, Univ Monash, Prince Henrys Inst Med Res, St Vincents Inst Med Res filed Critical Biotech Australia Pty Ltd

1995-03-15 Application granted granted Critical

1995-03-15 Publication of ATE118351T1 publication Critical patent/ATE118351T1/de

Links

229940088597 hormone Drugs 0.000 title 1
239000005556 hormone Substances 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 3
108010059616 Activins Proteins 0.000 abstract 2
102100026818 Inhibin beta E chain Human genes 0.000 abstract 2
108010004250 Inhibins Proteins 0.000 abstract 2
239000000488 activin Substances 0.000 abstract 2
238000002649 immunization Methods 0.000 abstract 2
230000003053 immunization Effects 0.000 abstract 2
239000000893 inhibin Substances 0.000 abstract 2
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 abstract 2
206010053567 Coagulopathies Diseases 0.000 abstract 1
102100025885 Inhibin alpha chain Human genes 0.000 abstract 1
102000002746 Inhibins Human genes 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
230000023555 blood coagulation Effects 0.000 abstract 1
208000026278 immune system disease Diseases 0.000 abstract 1
108010032856 inhibin-alpha subunit Proteins 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Absorbent Articles And Supports Therefor (AREA)
Lock And Its Accessories (AREA)

AT89906681T 1988-05-31 1989-05-31 Wirkung von hormonen. ATE118351T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPI853488		1988-05-31
AUPJ147088		1988-11-15

Publications (1)

Publication Number	Publication Date
ATE118351T1 true ATE118351T1 (de)	1995-03-15

Family

ID=25643485

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89906681T ATE118351T1 (de)	1988-05-31	1989-05-31	Wirkung von hormonen.

Country Status (5)

Country	Link
US (1)	US5196192A (de)
EP (1)	EP0368992B1 (de)
AT (1)	ATE118351T1 (de)
DE (1)	DE68921150T2 (de)
WO (1)	WO1989011862A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1341617C (en) *	1984-06-08	2011-06-28	Henry George Burger	Inhibin isolated from ovarian follicular fluid
WO1991012334A1 (en) *	1990-02-15	1991-08-22	Cetus Corporation	Inhibitor of cytokine activity and applications thereof
US5942220A (en) *	1990-03-16	1999-08-24	Chiron Corporation	Inhibitor of cytokine activity and applications thereof
CA2104678C (en)	1991-03-11	2002-05-14	Charles M. Cohen	Protein-induced morphogenesis
SE502569C2 (sv) *	1991-05-31	1995-11-13	British Tech Group	Användning av en immunologiskt inert matris av en sterol och saponiner som kan bilda sfäriska nanopartiklar med snäv storleksfördelning som läkemedelsbärare, partiklar, komposition samt kit
EP0661993B1 (de) *	1992-09-16	1997-05-07	Genentech, Inc.	Schutz gegen leberschäden mit hgf
US5658876A (en) *	1994-04-28	1997-08-19	The General Hospital Corporation	Activin antagonists as novel contraceptives
JPH11507663A (ja) *	1995-06-09	1999-07-06	イエダリサーチアンドデベロツプメントカンパニーリミテツド	レストリクチンｐ／アクチビンａを含む薬学的組成物及びｉｌ−６及び／又はｉｌ−１１のアンタゴニストとしてのその用途
GB2306481A (en) *	1995-10-21	1997-05-07	Univ Manchester	Pharmaceutical comprising a stimulator of activin and/or inhibin
AUPO638897A0 (en) *	1997-04-23	1997-05-22	Monash University	Modulation of cell growth and methods relating thereto
TW586934B (en) *	1997-05-19	2004-05-11	Sumitomo Pharma	Immunopotentiating composition
JPH11196864A (ja)	1998-01-08	1999-07-27	Deinabekku Kenkyusho:Kk	破骨細胞の分化を誘導する方法
EP0974650A1 (de) *	1998-07-22	2000-01-26	University Of Ioannina/Medical School	Inhibitoren des Endothelzellwachstums
AU780358B2 (en) *	1999-06-08	2005-03-17	Lorantis Limited	Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
WO2005032578A1 (en)	2003-10-06	2005-04-14	Monash University	Therapeutic method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4437485A (en) *	1984-06-08	1986-01-10	Biotechnology Australia Proprietary Limited	Inhibin isolated from ovarian follicular fluid
CA1341617C (en) *	1984-06-08	2011-06-28	Henry George Burger	Inhibin isolated from ovarian follicular fluid
AU5903986A (en) *	1985-04-18	1986-11-05	Biotechnology Australia Proprietary Limited	Recombinant inhibin
KR940004077B1 (ko) *	1985-04-18	1994-05-11	바이오테크놀로지 오스트레일리아 프로프라이어터리 리밋티드	재조합 인히빈
AU610821B2 (en) *	1985-04-18	1991-05-30	Inhibin Pty Limited	Recombinant inhibin
JPH0637520B2 (ja) *	1985-07-03	1994-05-18	味の素株式会社	ポリペプチド
NZ231899A (en) *	1985-10-03	1991-07-26	Genentech Inc	Human or porcine inhibin peptide compositions and dna encoding them
EP0299050B1 (de) *	1987-01-29	1995-03-22	Biotechnology Australia Pty. Ltd.	Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit
US5032507A (en) *	1987-11-13	1991-07-16	The Salk Institute For Biological Studies	Potentiation of erythropoiesis

1989
- 1989-05-31 DE DE68921150T patent/DE68921150T2/de not_active Expired - Fee Related
- 1989-05-31 EP EP89906681A patent/EP0368992B1/de not_active Expired - Lifetime
- 1989-05-31 WO PCT/AU1989/000245 patent/WO1989011862A1/en active IP Right Grant
- 1989-05-31 AT AT89906681T patent/ATE118351T1/de not_active IP Right Cessation
- 1989-05-31 US US07/459,704 patent/US5196192A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE68921150T2 (de)	1995-06-14
EP0368992A4 (en)	1991-04-03
DE68921150D1 (de)	1995-03-23
EP0368992B1 (de)	1995-02-15
EP0368992A1 (de)	1990-05-23
US5196192A (en)	1993-03-23
WO1989011862A1 (en)	1989-12-14

Publication	Publication Date	Title
DE68921150D1 (de)	1995-03-23	Wirkung von hormonen.
ES2125233T3 (es)	1999-03-01	Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
BR0007719A (pt)	2001-11-13	Baff, agentes de bloqueio relacionados e uso dosmesmos no estìmulo e na inibição de células b e deimunoglobulinas em respostas imunológicas
BG95935A (bg)	1993-12-24	Метод и средство за приемане на дексмедетомидин директно през кожата
DK0428038T3 (da)	1994-08-29	Transdermal administration af 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
BR9608612A (pt)	1999-05-04	Vacina compreendendo um conjugado de antígeno de polissacarídeo - proteína portadora e proteína portadora livre
SE9404196D0 (sv)	1994-12-02	New antithrombotic formulation
AU7814498A (en)	1998-12-30	Multivalent (in ovo) avian vaccine
NO20000378D0 (no)	2000-01-25	Anvendelse av MHC klasse II ligander som adjuvantia for vaksinasjon og LAG-3 i kreftbehandling
FI972703A0 (fi)	1997-06-23	Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
NL300189I1 (nl)	2005-06-01	Acellulair vaccin.
MX9101958A (es)	1992-07-08	Inhibidores de acat de urea de aminosulfonilo
DK0561846T3 (da)	1995-08-21	4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DE69010523D1 (de)	1994-08-18	Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DK0835309T3 (da)	2002-12-02	Vaccine imod infektiøse agenser, præparat til behandling og forebyggelse af HIV infektioner
DE3878529D1 (de)	1993-03-25	Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
DE3879837D1 (de)	1993-05-06	Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
FR2652502B1 (fr)	1993-12-24	Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent.
DE3776662D1 (de)	1992-03-19	Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DE68914886D1 (de)	1994-06-01	Mittel zur Behandlung von Raynaud's Krankheit.
DE3789760D1 (de)	1994-06-09	Orale Hyposensibilisierung bei der Behandlung von Allergien.
DE59101251D1 (de)	1994-05-05	Vorrichtung, insbesondere zum Verabreichen von Voll- oder Sitzbädern.
FI864917A0 (fi)	1986-12-02	System vid godsvagn som goer den maongsidigare i bruk.

Legal Events

Date	Code	Title	Description
1995-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties